Table E3.

Characteristics of all recipients without adverse events following immunization (AEFI) and matched controls

Demographic characteristic	Recipients without AEFI (N = 611,238)	Controls 1 (N = 1224)	Controls 2 (N = 9912)
Age (y)
>65	196,168 (32)	467 (38)	2344 (26)
51-65	130,158 (21)	258 (21)	1913 (18)
36-50	140,193 (23)	264 (22)	2815 (29)
≤35	144,718 (24)	235 (19)	2840 (27)
Period at first dose
May 24-June 23	235,749 (39)	591 (48)	3047 (31)
June 24-July 23	91,500 (15)	167 (14)	551 (6)
July 24-August 23	229,085 (37)	415 (34)	5334 (54)
August 24-September 24	55,106 (9)	48 (4)	957 (10)
Period at second dose
May 24-June 23	782 (0)	0 (0)	2 (0)
June 24-July 23	254,220 (42)	532 (44)	2603 (27)
July 24-August 23	73,884 (12)	128 (11)	891 (9)
August 24-September 24	260,948 (43)	533 (45)	6282 (64)

Data are presented as n (%).